Evidence map›Paper›PMID 27792871›Full record

ReviewArthritis & rheumatology (Hoboken, N.J.)2017

Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.

Jane C Burns, Isabelle Koné-Paut, Taco Kuijpers, Chisato Shimizu, Adriana Tremoulet, Moshe Arditi

Abstract readReview
In one paragraph

Review in Arthritis & rheumatology (Hoboken, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. The etiologies of Kawasaki disease.The Journal of clinical investigation · 2024
    Review
  14. Article
  15. Macrophage Activation Syndrome in the Setting of Rheumatic Diseases.Advances in experimental medicine and biology · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jane C BurnsUniversity of California at San Diego, La Jolla, and Rady Children's Hospital, San Diego, California.
Isabelle Koné-PautNational Reference Center for Autoinflammatory Diseases, Bicêtre Hospital, AP-HP, University of Paris Sud, Paris, France.
Taco KuijpersEmma Children's Hospital, University of Amsterdam, Amsterdam, The Netherlands.
Chisato ShimizuUniversity of California at San Diego, La Jolla, and Rady Children's Hospital, San Diego, California.
Adriana TremouletUniversity of California at San Diego, La Jolla, and Rady Children's Hospital, San Diego, California.
Moshe ArditiCedars-Sinai Medical Center and UCLA School of Medicine, Los Angeles, California.

Funding

Role of IL-1 in Bacterial ligand-induced vasculitis and myocarditisR01AI072726 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI ARDITI, MOSHE · 2008 to 2020
$4.5M
Impact of TNFa blockade on immune function in acute Kawasaki diseaseR01HL103536 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BURNS, JANE C, FRANCO, ALESSANDRA I · 2010 to 2013
$1.5M
Innate Immunity and Mouse Model of Kawasaki DiseaseK08AI070162 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI SCHULTE, DANICA JENINE · 2007 to 2010
$508k
NHLBI NIH HHS R01 HL103536NIAID NIH HHS K08 AI070162NIAID NIH HHS R01 AI072726
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute DiseaseAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntirheumatic AgentsClinical Trials, Phase I as TopicClinical Trials, Phase II as TopicHumansImmunoglobulins, IntravenousInterleukin-1Interleukin 1 Receptor Antagonist ProteinMucocutaneous Lymph Node SyndromeTranslational Research, BiomedicalTumor Necrosis Factor-alphaAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntirheumatic AgentscanakinumabImmunoglobulins, IntravenousInterleukin-1Interleukin 1 Receptor Antagonist ProteinTumor Necrosis Factor-alpha

Identifiers

PMID27792871
PMCPMC5274552

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.